Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.

apathy dopamine executive function motivation subthalamic nucleus

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
03 Oct 2023
Historique:
received: 23 03 2023
revised: 13 07 2023
accepted: 21 08 2023
medline: 3 10 2023
pubmed: 3 10 2023
entrez: 3 10 2023
Statut: aheadofprint

Résumé

Postoperative apathy is a frequent symptom in Parkinson's disease patients who have undergone bilateral deep brain stimulation of the subthalamic nucleus. Two main hypotheses for postoperative apathy have been suggested: i) dopaminergic withdrawal syndrome relative to postoperative dopaminergic drug tapering and ii) direct effect of chronic stimulation of the subthalamic nucleus. The primary objective of our study was to describe preoperative and one-year postoperative apathy in Parkinson's disease patients who underwent chronic bilateral deep brain stimulation of the subthalamic nucleus. We also aimed to identify factors associated with one-year postoperative apathy considering: i) preoperative clinical phenotype, ii) dopaminergic drug management and iii) volume of tissue activated within the subthalamic nucleus and the surrounding structures. We investigated a prospective clinical cohort of 367 patients before and one year after chronic bilateral deep brain stimulation of the subthalamic nucleus. We assessed apathy using the Lille Apathy Rating Scale and carried out a systematic evaluation of motor, cognitive, and behavioral signs. We modelled the volume of tissue activated in 161 patients using Lead DBS toolbox and analyzed overlaps within motor, cognitive and limbic parts of the subthalamic nucleus. Of the 367 patients, 94 (25.6%) exhibited one-year postoperative apathy: 67 (18.2%) with "de novo apathy" and 27 (7.4%) with "sustained apathy". We observed disappearance of preoperative apathy in 22 (6.0%) patients, who were classified as having "reversed apathy". Lastly, 251 (68.4%) patients had neither preoperative nor postoperative apathy and were classified as having "no apathy". We identified preoperative apathy score (OR 1.16, IC95% [1.10 ; 1.22], p<0.001), preoperative episodic memory free recall score (OR 0.93, IC95% [0.88 ; 0.97], p=0.003), and one-year postoperative motor responsiveness (OR 0.98, IC95% [0.96 ; 0.99], p=0.009) as the main factors associated with postoperative apathy. We showed that neither dopaminergic dose reduction nor subthalamic stimulation were associated with postoperative apathy. Patients with "sustained apathy" had poorer preoperative fronto-striatal cognitive status and higher preoperative action initiation apathy subscore. In these patients, apathy score and cognitive status worsened postoperatively despite significantly lower reduction in dopamine agonists (p=0.023), suggesting cognitive dopa-resistant apathy. Patients with "reversed apathy" benefited from the psychostimulant effect of chronic stimulation of the limbic part of the left STN (p=0.043), suggesting motivational apathy. Our results highlight the need for careful preoperative assessment of motivational and cognitive components of apathy as well as executive functions in order to better prevent or manage post-operative apathy.

Identifiants

pubmed: 37787488
pii: 7287979
doi: 10.1093/brain/awad324
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Matthieu Béreau (M)

Department of Neurology, NS-PARK/F-CRIN network, University Hospital of Besançon, 25030 Besançon Cedex, France.
Université de Franche-Comté, UR LINC 481, Besançon F-2500, France.

Astrid Kibleur (A)

Laboratoire Interuniversitaire de Psychologie, Personnalité, Cognition et Changement Social, LIP/PC2S, Université Savoie Mont Blanc, BP 1104, 73011 Chambéry, France.

Mathieu Servant (M)

Université de Franche-Comté, UR LINC 481, Besançon F-2500, France.

Gautier Clément (G)

Department of Neurology, NS-PARK/F-CRIN network, University Hospital of Besançon, 25030 Besançon Cedex, France.

Kathy Dujardin (K)

Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN network, 59037 Lille, France.

Anne-Sophie Rolland (AS)

Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Department of Medical Pharmacology, NS-Park/F-CRIN, 59045 Lille Cedex, France.

Thomas Wirth (T)

Service de Neurologie, NS-Park/F-CRIN network, Hôpitaux Universitaires de Strasbourg et Fédération de Médecine Translationnelle de Médecine de Strasbourg, 67200 Strasbourg, France.
Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM-U964/CNRS-UMR7104/Université de Strasbourg, 67400 Illkirch, France.

Ouhaid Lagha-Boukbiza (O)

Service de Neurologie, NS-Park/F-CRIN network, Hôpitaux Universitaires de Strasbourg et Fédération de Médecine Translationnelle de Médecine de Strasbourg, 67200 Strasbourg, France.

Jimmy Voirin (J)

Department of Neurosurgery, NS-PARK/F-CRIN network, Strasbourg University Hospital, 67200 Strasbourg, France.

Marie des Neiges Santin (M)

Department of Neurosurgery, NS-PARK/F-CRIN network, Strasbourg University Hospital, 67200 Strasbourg, France.

Elodie Hainque (E)

Sorbonne Université, Paris Brain Institute - ICM, NS-Park/F-CRIN network, Assistance publique Hôpitaux de Paris, Inserm, CRNS, Hôpital Pitié-Salpêtrière, Department of Neurology, 75014 Paris, France.

David Grabli (D)

Sorbonne Université, Paris Brain Institute - ICM, NS-Park/F-CRIN network, Assistance publique Hôpitaux de Paris, Inserm, CRNS, Hôpital Pitié-Salpêtrière, Department of Neurology, 75014 Paris, France.

Alexandre Comte (A)

Université de Franche-Comté, UR LINC 481, Besançon F-2500, France.
Inserm, CIC 1431, CHU de Besançon, F-25000, France.

Sophie Drapier (S)

Department of Neurology, NS-PARK/F-CRIN network, University Hospital of Rennes, 35000 Rennes, France.

Franck Durif (F)

Université Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, NS-Park/F-CRIN network, 63000 Clermont-Ferrand, France.

Ana Marques (A)

Université Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, NS-Park/F-CRIN network, 63000 Clermont-Ferrand, France.

Alexandre Eusebio (A)

APHM, Hôpital Universitaire Timone, Department of Neurology and Movement Disorders, Marseille, France.
Aix Marseille Univ, CNRS, Institut de Neurosciences de la Timone, 13005 Marseille, France, 06002 Nice, France.

Jean-Philippe Azulay (JP)

APHM, Hôpital Universitaire Timone, Department of Neurology and Movement Disorders, Marseille, France.
Aix Marseille Univ, CNRS, Institut de Neurosciences de la Timone, 13005 Marseille, France, 06002 Nice, France.

Caroline Giordana (C)

Department of Neurology, NS-Park/F-CRIN network, Centre Hospitalier Universitaire de Nice, 06002 Nice, France.

Jean-Luc Houeto (JL)

Department of Neurology, NS-Park/F-CRIN network, Limoges University Hospital; Inserm, U1094, EpiMaCT - Epidemiology of chronic diseases in tropical zone, 87042 Limoges Cedex 01, France.

Béchir Jarraya (B)

Neuroscience Pole, NS-Park/F-CRIN network, Hôpital Foch, Suresnes, University of Versailles Paris-Saclay, INSERM-CEA NeuroSpin, 91191 Gif-sur-Yvette, France.

David Maltete (D)

Department of Neurology, NS-Park/F-CRIN network, Rouen University Hospital and University of Rouen, 76000 Rouen, France.
INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, 76130 Mont-Saint-Aignan, France.

Olivier Rascol (O)

Department of Clinical Pharmacology and Neuroscience, CIC1436, NS-Park/F-CRIN network, NeuroToul Center of Excellence, Toulouse University Hospital, INSERM, CHU of Toulouse, 31000 Toulouse, France.

Tiphaine Rouaud (T)

Department of Neurology, Centre Expert Parkinson, NS-Park/F-CRIN network, CHU Nantes, 44093 Nantes, France.

Mélissa Tir (M)

Department of Neurology, NS-PARK/FCRIN, Amiens University Hospital, 80000 Amiens, France.

Caroline Moreau (C)

Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN network, 59037 Lille, France.

Teodor Danaila (T)

Department of Neurology, NS-PARK/FCRIN, Amiens University Hospital, 80000 Amiens, France.

Stéphane Prange (S)

Department of Neurology, NS-PARK/FCRIN, Amiens University Hospital, 80000 Amiens, France.
Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, NS-Park/F-CRIN network, 69500 Bron, France.

Laurent Tatu (L)

Department of Neurology, NS-PARK/F-CRIN network, University Hospital of Besançon, 25030 Besançon Cedex, France.

Christine Tranchant (C)

Service de Neurologie, NS-Park/F-CRIN network, Hôpitaux Universitaires de Strasbourg et Fédération de Médecine Translationnelle de Médecine de Strasbourg, 67200 Strasbourg, France.

Jean-Christophe Corvol (JC)

Sorbonne Université, Paris Brain Institute - ICM, NS-Park/F-CRIN network, Assistance publique Hôpitaux de Paris, Inserm, CRNS, Hôpital Pitié-Salpêtrière, Department of Neurology, 75014 Paris, France.

David Devos (D)

Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN network, 59037 Lille, France.
Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Department of Medical Pharmacology, NS-Park/F-CRIN, 59045 Lille Cedex, France.

Stephane Thobois (S)

Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, NS-Park/F-CRIN network, 69500 Bron, France.
Institut des Sciences Cognitives Marc Jeannerot, CNRS, UMR5229, 69675 Bron Cedex, France.

Maxime Desmarets (M)

Centre d'Investigation Clinique (Inserm CIC1431), CHU Besançon, 25000 Besançon, France.
Université de Franche-Comté, EFS, INSERM, UMR RIGHT, 25000 Besançon, France.

Mathieu Anheim (M)

Service de Neurologie, NS-Park/F-CRIN network, Hôpitaux Universitaires de Strasbourg et Fédération de Médecine Translationnelle de Médecine de Strasbourg, 67200 Strasbourg, France.
Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM-U964/CNRS-UMR7104/Université de Strasbourg, 67400 Illkirch, France.

Classifications MeSH